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In mouse development, long-term silencing by CpG island DNA methylation is specifically
targeted to germline genes; however, the molecular mechanisms of this specificity remain
unclear. Here, we demonstrate that the transcription factor E2F6, a member of the polycomb
repressive complex 1.6 (PRC1.6), is critical to target and initiate epigenetic silencing at
germline genes in early embryogenesis. Genome-wide, E2F6 binds preferentially to CpG
islands in embryonic cells. E2F6 cooperates with MGA to silence a subgroup of germline
genes in mouse embryonic stem cells and in embryos, a function that critically depends on
the E2F6 marked box domain. Inactivation of E2f6 leads to a failure to deposit CpG island
DNA methylation at these genes during implantation. Furthermore, E2F6 is required to
initiate epigenetic silencing in early embryonic cells but becomes dispensable for the main-
tenance in differentiated cells. Our findings elucidate the mechanisms of epigenetic targeting
of germline genes and provide a paradigm for how transient repression signals by DNA-
binding factors in early embryonic cells are translated into long-term epigenetic silencing
during mouse development.
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Methylation of cytosines in CpG dinucleotides by theDNA methyltransferases (DNMTs) is one of the best-characterized epigenetic control mechanisms for gene
transcription. In mice, genome-wide DNA methylation patterns
are established during a short wave of de novo methylation
concomitant to embryo implantation1,2. During this develop-
mental stage, Dnmt3a and Dnmt3b deposit DNA methylation
throughout the genome3.
In contrast to interspersed CpG dinucleotides, the majority of
genomic regions of high CpG density, known as CpG islands
(CGIs), are protected against DNA methylation. In post-
implantation embryos, <1% of CGIs at transcription start sites
(TSSs) have acquired DNA methylation3. The mechanisms
underlying the protection of CGIs from DNA methylation are
still poorly understood. CGIs tether proteins containing CXXC
zinc finger DNA-binding domains that recognize unmethylated
CpG-containing DNA. Some of these CXXC proteins have been
implicated in the protection against DNA methylation4. CGIs
also harbor high levels of H3K4 trimethylation known to inhibit
the activity of DNMT3 methyltransferases and de novo DNA
methylation5–8. In addition, several studies suggest that binding
of activating transcription factors (TFs) at CGIs contributes to
protection against DNA methylation9–13.
Strikingly, promoter CGI methylation in development is
almost exclusively observed at germline genes3. Suppression of
transcription of germline genes in somatic cells depends on DNA
methylation, as they are derepressed in DNA methylation-
deficient mouse embryos and in response to inhibitors of DNA
methylation3,14,15. However, the molecular mechanisms leading
to DNA methylation, specifically at CGIs of germline genes, are
unknown. Existing evidence suggests that the TF E2F6 could play
a role in this process. E2F6 is a member of the E2F family of TFs
that control cell proliferation and cell fate16–19. E2F6 serves as a
transcriptional repressor that binds the DNA site 5′-TCCCGC-3′,
which is highly conserved in promoter regions of meiosis-specific
genes20. For the Tuba3a gene, E2F6-dependent gene repression in
somatic cells involves promoter DNA methylation21. Interest-
ingly, somatic cells lacking E2F6 or DNMT3B show overlapping
sets of derepressed genes1,22, further suggesting a link between
E2F6 and DNA methylation. Based on experiments in somatic
cells, a direct recruitment of DNMT3B by E2F6 has been
suggested22.
In mammalian cells, E2F6 interacts with components of the
polycomb repressive complex PRC1.623–28. PRC1.6 is one of the
non-canonical PRC1 (ncPRC1) complexes that are recruited to
chromatin independently of H3K27 methylation. Targeting of
ncPRC1 complexes can involve recognition of unmethylated
CGIs through the CXXC domain of KDM2B29. The PRC1.6
complex lacks the KDM2B subunit but contains RYBP, PCGF6,
L3MBTL2, RING1A/B, CBX3, YAF2, WDR5, and the DNA-
binding TFs E2F6/DP1 and MGA/MAX24,26. Interestingly MAX,
MGA, PCGF6, L3MBTL2, and RYBP have been linked to the
repression of germline genes in mouse embryonic stem cells
(ESCs)24,30–34. In contrast to the other components of PRC1.6,
the biological roles and targets of E2F6 have been less explored.
Here we investigated the biological functions of E2F6 in the
mouse and the hypothesis that E2F6 may play an essential role in
initiating long-term epigenetic repression of germline genes
during embryogenesis.
Results
E2F6 genomic targets and protein partners in mouse ESC cells.
To start investigating the role of E2F6, we performed chromatin
immunoprecipitation-sequencing (ChIP-seq) analysis of E2F6
in E2f6+/+ and E2f6−/− mouse ESCs established from E2f6-
knockout (KO) and control mice21 (Supplementary Data 1). This
analysis generated 2533 high confidence peaks (Supplementary
Data 2). The established E2F6 target gene Tuba3a21 revealed a
well-defined peak over its TSS (Fig. 1a). Importantly, all peaks
were not detected in control ChIP-seq derived from E2f6−/−
ESCs, thereby confirming the specificity of the immunoprecipi-
tation (Fig. 1a and Supplementary Fig. 1a). The majority of E2F6
peaks were located close to TSSs and colocalize with CGIs
(Fig. 1b, c). Sequence motif analysis of the E2F6 ChIP-seq peaks
revealed that they are enriched for the E2F6-binding site 5′-
TCCCGC-3′ (2153/2533 peaks, p= 2.91e− 129) and the E-box
motif 5′-CACGTG-3′ bound by MAX/MGA (661/2533 peaks,
p= 3.80e− 65) (Fig. 1d, e and Supplementary Fig. 1b). Gene
Ontology (GO) analysis of E2F6-bound gene promoters revealed
an enrichment for gene functions associated with cell cycle, DNA
replication, response to DNA damage, and meiosis (Supplemen-
tary Data 2), which is in line with known functions of E2F6 that
binds to genes activated by E2F TFs during the G1/S transition of
the cell cycle17,35.
Next, we compared E2F6 ChIP-seq with publicly available
ChIP-seq datasets in mouse ESCs, in particular ChIP-seq of the
PRC1.6 subunits. This revealed that E2F6 ChIP-seq profiles
cluster with datasets of other components of the PRC1.6 complex
including MAX, MGA, L3MBTL2, RYBP, and PCGF6 (Supple-
mentary Fig. 1c). Indeed, E2F6 peaks in the genome show
frequent binding of the other PRC1.6 subunits (Fig. 1f, g and
Supplementary Fig. 1d). Furthermore, a comparison of the peaks
of E2F6, MGA, and L3MBTL2 revealed a high degree of overlap
(Supplementary Fig. 1e), further indicating that E2F6 and PRC1.6
frequently bind to the same genomic loci.
To identify E2F6-associated proteins, we generated ESCs stably
expressing an hemagglutinin (HA)-tagged version of E2F6
(Fig. 1h) and performed immunoprecipitation on nuclear extracts
followed by mass spectrometry (MS). We found a strong
association of E2F6 with MGA, L3MBTL2, PCGF6, DP1,
RING1A/B, and MAX (Fig. 1i), confirming that E2F6 associates
with members of the PRC1.6 complex. RYBP was also detected
below the threshold of significance (Supplementary Data 3).
Other significant hits were SKT and KI-67, as well as cytoskeletal
proteins that might be nonspecific contaminants (Supplementary
Data 3). The interaction between HA-tagged E2F6 and
endogenous MGA, PCGF6, and L3MBTL2 was confirmed by
western blotting (Fig. 1j).
In summary, these results show that E2F6 is frequently bound
to CpG-rich promoters and colocalizes with the PRC1.6 complex
genome wide in mouse ESCs.
E2F6 represses germline genes in mouse ES cells and in vivo.
To test whether E2F6 binding is causatively involved in tran-
scriptional regulation, we performed RNA sequencing (RNA-seq)
in E2f6+/+ and E2f6−/− ESCs (Supplementary Data 1 and Sup-
plementary Fig. 2a, b), and identified 187 genes significantly
upregulated (fold change >3; adjusted p-value < 0.0001) upon
E2f6-KO (Fig. 2a and Supplementary Data 4). Thus, most genes
bound by E2F6 are not transcriptionally deregulated in E2f6−/−
ESCs. In particular, the transcription of G1/S-induced E2F target
genes known to be occupied by E2F6 (e.g., Pcna, Rrm1, Cdc6, and
Tk1) was not affected in E2f6-KO cells (Supplementary Fig. 2c),
consistent with previous findings in somatic cells17. Rather, GO
analysis showed that the upregulated genes are enriched for GO
terms related to germ cells (meiotic cell cycle p= 7.62e− 12;
reproductive process p= 2.73e− 9, Supplementary Data 4).
Twenty-four out of 37 genes that simultaneously have an E2F6
peak in their promoter and are upregulated in E2f6−/− ESCs
are known germline-specific genes (Supplementary Fig. 2d),
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indicating that germline genes are the main direct targets of E2F6.
Genes upregulated in E2f6−/− cells without E2F6 binding prob-
ably reflect indirect or clonal effects. These germline genes
include the previously known targets of E2F6 Tuba3a, Slc25a31,
Smc1b, and Stag320,21,36 (Supplementary Fig. 2d, e). ChIP-seq
profiles confirm that these germline genes have strong
E2F6 signal in their promoter (Supplementary Fig. 3a). Further-
more, derepression of a subset of these germline genes in E2f6−/−
ESCs was validated by reverse-transcriptase quantitative PCR
(RT-qPCR) (Fig. 2b) and E2F6 binding was validated by ChIP-
qPCR at all germline gene promoters tested (Fig. 2c). This
demonstrates that E2F6 plays a merely redundant role in the
repression of most of its targets but is indispensable for silencing
a group of germline genes in ESCs.
To test whether E2F6 plays similar functions in vivo, we
analyzed embryos of E2f6-KO mice37. RNA-seq in E2f6−/−
and control embryos dissected at E8.5 (Supplementary Data 1
and Supplementary Fig. 2a, b) identified 34 upregulated genes
(fold change >3; adjusted p-value < 0.0001) (Fig. 2d and Supple-
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Fig. 1 ChIP-seq analysis and interactome of E2F6 in ES cells. a Genome browser tracks showing E2F6 ChIP-seq and input signals in E2F6+/+ and E2f6−/−
ESCs over the Tuba3a gene. UCSC CGI and RefSeq gene annotations are shown below the tracks. b Density histogram representing the distance of E2F6
peak summits to their closest TSS (n= 2533). c Percentage of E2F6 peaks overlapping with annotated UCSC CpG islands (CGIs). d The E2F6 and MAX E-
box CACGTG motifs are the most enriched sequence motifs identified in E2F6 peaks (p-value: hypergeometric test). e Metaplot representing the position
of E2F6 and MAX E-box motifs relative to the summits of E2F6 peaks (n= 2533). f Genome browser tracks of ChIP-seq signals in mouse ESCs showing
that E2F6 peaks frequently colocalize with peaks of other PRC1.6 subunits. UCSC CGI and RefSeq gene annotations are shown below the tracks.
g Heatmaps of E2F6, MGA, L3MBTL2, PCGF6, RYBP, and RING1B ChIP-seq read densities ±2.5 kb around E2F6 peak summits (n= 2533), ordered by E2F6
read densities. hWestern blotting with an anti-E2F6 antibody showing the expression of the tagged E2F6 in ESCs transfected with 3×HA-E2F6. α-TUBULIN
was used as a loading control. i. Volcano plot of E2F6 interaction partners in ESCs. Anti-HA immunoprecipitation was performed on nuclear extracts
from control ESCs and ESCs expressing 3×HA-E2F6 (n= 5 independent experiments). Significantly enriched proteins are indicated in red. j Co-
immunoprecipitation of E2F6 with PRC1.6 in mouse ESCs. Western blotting was performed on the input and anti-HA immunoprecipitate from control ESCs
and ESCs expressing 3×HA-E2F6 using the indicated antibodies. GLP was used as a control nuclear protein that does not interact with E2F6. Source data
are provided as a Source Data file.
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terms related to germ cells (meiotic cell cycle p= 6.96e− 16;
reproductive process p= 3.82e− 9, Supplementary Data 5) and
significantly overlapped with the genes upregulated in ESCs
(Fig. 2e, p= 5.41e− 39, hypergeometric test), revealing a core set
of 17 germline genes repressed by E2F6 in ESCs and embryos,
whereas a small number of germline genes was found strongly
derepressed only in embryos (Fig. 2e). The derepression of
germline genes in E2f6−/− embryos was validated by RT-qPCR
(Fig. 2f). In summary, these results show that E2F6 is
indispensable to repress a group of germline genes in ESCs and
in vivo.
E2F6 cooperates with MGA for the silencing of germline genes.
Germline genes repressed by E2F6 show binding of MGA, the
other DNA-binding subunit of PRC1.6 previously implicated in
the repression of germline genes in ESCs30 (Supplementary
Fig. 3a). As it is well known that ChIP peaks may result from
indirect recruitment, we searched for E-box motifs recognized by
MAX/MGA and found that several E2F6 target genes contain an
E-box motif in their promoter (Fig. 3a). This raises the question
whether E2F6 and MGA cooperate for the regulation of germline
genes.
First, we compared the expression of germline genes in E2f6−/−
and Mga-knockdown ESCs30. A comparative analysis revealed
that most of the E2F6 target genes are concomitantly repressed by
MGA (Fig. 3b), indicating that E2F6 and MGA share a set of
target genes related to germline functions in ESCs. MGA also
represses additional germline genes that are not repressed by
E2F6, such as Tex101, Tdrd9, Taf7l, Mov10l1, or Tex19.2 (Fig. 3b
and Supplementary Fig. 3b). However, as shown previously33, we
found that knockdown of MGA resulted in a strong reduction of
E2F6 protein levels in ESCs (Supplementary Fig. 4a). This is due to
protein destabilization at the posttranscriptional level, because
MGA knockdown does not lead to reduced levels of E2f6 mRNA
transcripts (Supplementary Fig. 4b) and treatment with the
MG132 proteasome inhibitor slightly increases the levels of E2F6
protein in MGA-kd ESCs (Supplementary Fig. 4a). To circumvent
this confounding effect and test whether E2F6 and MGA synergize
for the repression of germline genes, we depleted MGA by short
hairpin RNA (shRNA) in E2f6−/− ESCs. Knockdown of MGA in
E2f6−/− cells resulted in an additional derepression of the E-box-
containing genes Slc25a31 and Tex12, but did not further affect
the expression of the E-box-lacking gene Tuba3a (Fig. 3c). In
comparison to MGA, the knockdown of MAX had a weaker effect
on the derepression of E-box-containing genes (Fig. 3c). Alto-
gether, these results show that E2F6 and MGA cooperate for the
silencing of germline genes with E-box-containing promoters.
Next, we investigated whether E2F6 participates in PRC1.6
recruitment to germline genes. Importantly, protein levels of
PRC1.6 subunits are unaffected in E2f6-KO ESCs, suggesting that
the PRC1.6 complex is intact in E2f6-null cells (Supplementary
Fig. 4c). We performed ChIP-qPCR analysis of RYBP and PCGF6
Fig. 2 Identification of genes repressed by E2F6 in ES cells and embryos. a Scatter plot comparing the normalized RNA-seq read counts for all RefSeq
genes in E2f6+/+ vs. E2f6−/− ESCs. Genes significantly upregulated or downregulated (fold change > 3; adjusted p-value < 0.0001) are highlighted in green
and red, respectively. b Expression of E2F6 target genes by RT-qPCR in E2f6−/− ESCs. Shown is the fold change (FC) relative to WT cells (mean ± SEM,
n= 3 independent experiments, expression normalized to Gusb, Rpl13a, and Mrpl32). c ChIP-qPCR analysis of the binding of E2F6 in the promoters of E2F6
target genes in WT and E2f6−/− ESCs (mean ± SEM, n= 3 independent experiments). d Scatter plot comparing the normalized RNA-seq read counts for all
RefSeq genes in WT and E2f6−/− E8.5 embryos. Genes significantly upregulated or downregulated (fold change > 3; adjusted p-value < 0.0001) are
highlighted in green and red, respectively. e Venn diagram comparing the genes upregulated in E2f6−/− ESCs and E2f6−/− embryos. The names of
germline genes significantly upregulated in E2f6−/− ESCs and embryos or E2f6−/− embryos only are indicated. p-value: hypergeometric test. f Expression
of E2F6 target genes by RT-qPCR in E2f6−/− embryos (mean fold change relative to WT, n= 2 embryos, expression normalized to Actb and Rpl13a). Source
data are provided as a Source Data file.
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on six E2F6 target genes that either contain only an E2F6-binding
motif in their promoter or both an E2F6 motif and E-box motif
(Fig. 3a). Interestingly, RYBP and PCGF6 binding was reduced in
E2f6−/− ESCs specifically in those promoters lacking E-box
motifs (Fig. 3d, genes marked in gray). This suggests that E2F6
participates in the recruitment of PRC1.6, but that in the presence
of E-boxes the MAX/MGA subunits are sufficient to tether
PRC1.6 in the absence of E2F6 protein. Against our expectations,
the undisturbed presence of PRC1.6 on E-box-containing gene
promoters in E2f6−/− ESCs indicates that on these promoters,
E2F6-dependent gene repression is decoupled from PRC1.6
recruitment. To further assess the contribution of PRC1.6 to the
regulation of germline genes repressed by E2F6, we compared
expression changes in E2f6-KO ESCs and ESCs inactivated for
Pcgf6 or Ring1a/b, the catalytic subunits of PRC1 complexes30.
Interestingly, Pcgf6-KO and Ring1a/b double KO (DKO) ESCs
undergo limited upregulation of E2F6 target genes compared to
E2f6-KO and Mga-Kd ESCs (Fig. 3e). Collectively, these results
suggest that E2F6 represses germline genes in part by PRC1.6-
independent mechanisms.
E2F6 function depends on its marked box domain. We went on
to investigate the role of E2F6 domains in the repression of
germline genes by rescue experiments with wild-type (WT) and
mutant versions of E2F6 in E2f6−/− ESCs (Fig. 4a, b). Stable re-
expression of WT HA-tagged E2F6 in E2f6−/− ESCs restored the
repression of Tuba3a (Fig. 4c). In contrast, a mutant version of
E2F6 (E68) carrying a point mutation of the DNA-binding
domain18 failed to bind to the Tuba3a promoter and rescue
Tuba3a silencing (Fig. 4c). Previous studies showed that the
marked box domain of E2F proteins mediate their target gene
specificity38. To test the importance of the E2F6 marked box
domain, we re-expressed a chimeric E2F6 harboring the marked
box of E2F4 (E2F6-MB4, Fig. 4a), an E2F family member that can
compensate the loss of E2F6 in cell cycle regulation17. This
mutant E2F6 was able to bind to the Tuba3a promoter but failed
to rescue Tuba3a repression (Fig. 4c). Thus, repression of the
Tuba3a gene by E2F6 requires the DNA-binding and marked box
domains of E2F6.
During cell cycle progression, activating E2Fs (such as E2F1)
and E2F6 occupy E2F-responsive promoters sequentially17,35.
Strikingly, we found that one distinctive feature of germline genes
actively repressed by E2F6 is high E2F6 binding and reduced
E2F1 binding (Fig. 4d), suggesting that E2F6 has the ability to
specifically outcompete E2F1 binding at its target genes. To test
this hypothesis, we analyzed E2F1 binding by ChIP-qPCR in the
Tuba3a promoter. In E2f6−/− ESCs, the promoter of the
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Fig. 3 Cooperation between E2F6 and MGA in ES cells. a Position of E2F6-binding sites (orange triangles) and MAX E-boxes (green diamonds) in the
promoter regions (−500 to +500 bp relative to the start of transcription) of E2F6 target genes. The arrow indicates the position of the TSS. The genes
containing only an E2F6 motif are written in gray. b Heatmap comparing the changes in gene expression of germline genes in E2f6−/− andMga-knockdown
ESCs30. MGA represses the E2F6 target genes (top of the heatmap) but also other germline genes not repressed by E2F6 (bottom of the heatmap). c RT-
qPCR quantification of the expression of E2F6 target genes without (Tuba3a) or with E-boxes (Slc25a31, Tex12) in E2f6−/− ESCs expressing an shRNA
against MGA, MAX, or a scramble control (shRNA Scr). The results are represented as a fold change relative to the scramble control (mean ± SEM, n= 3
independent experiments, expression normalized to Actb). p-values: two-tailed t-test. d ChIP-qPCR analysis of the binding of RYBP and PCGF6 to
promoters of E2F6 target genes in WT and E2f6−/− ESCs. The results are represented as the percentage of signal relative to the input (mean ± SEM, n= 3
independent experiments). For each condition, the values from the ChIP (left) and IgG control (right) are shown. The genes containing only an E2F6 motif
are written in gray. e Gene expression (plotted as FPKM values) of E2F6 target germline genes (n= 24 genes) in E2f6-KO,Mga knockdown, Ring1a/b DKO,
and Pcgf6-KO ESCs30 (paired Wilcoxon test, E2f6: p= 1.19e− 7, Mga: p= 2.38e− 7, Ring1a/b: p= 8.35e− 6, Pcgf6: p= 1.19e− 7). In the boxplots, the line
indicates the median, the box limits indicate the upper and lower quartiles, and the whiskers extend to 1.5 IQR from the quartiles. Source data are provided
as a Source Data file.
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Re-expression of exogenous WT E2F6 but not the E68 or MB4
mutants precluded E2F1 binding as efficiently as endogenous
E2F6 in WT ESCs (Fig. 4e), demonstrating that E2F6 efficiently
outcompetes E2F1 for promoter binding at the Tuba3a promoter.
To investigate whether the ability of E2F6 to evict E2F1
results from different DNA-binding capabilities, we generated a
swap-mutant of E2F6 (E2F6-DBD1) in which the DNA-binding
domain of E2F6 was replaced by the corresponding
E2F1 sequence (Fig. 4a). All attempts to establish stable
transfected E2f6−/− ESC clones expressing E2F6-DBD1 failed
and fluorescence-activated cell sorting analysis of transduced ESC
pools revealed a strong counter selection against E2F6-DBD1-
expressing cells (data not shown). However, expression analysis
of cellular pools 4 days after lentiviral transduction into E2f6−/−
ESCs demonstrates that the DNA-binding domains of E2F6 and
E2F1 are functionally redundant in mediating repression of E2F6
target genes, in contrast to the E2F6-MB4 mutant that is unable
to restore repression of germline genes (Fig. 4f). Therefore, the
observed competitive advantage of E2F6 over E2F1 at germline
genes is not linked to its DNA-binding domain and is mediated
by the marked box domain.
Altogether, this shows that E2F6 target gene specificity and its
ability to oppose activating TFs critically depend on its marked
box domain.
E2F6 represses germline genes by DNA methylation-
independent mechanisms in early embryonic cells. We then
further explored the epigenetic mechanisms of E2F6-mediated
repression of germline genes. Given that germline genes undergo
long-term repression by promoter DNA methylation during
development, we investigated the interplay between E2F6 and
DNA methylation. First, we asked whether E2F6 represses
germline genes in preimplantation embryonic cells prior to the
phase of global DNA methylation establishment. To this end, we
measured the expression of the E2F6 target genes Tuba3a and
Hormad1 in E2f6+/+ and E2f6−/− blastocysts, and found that
these genes are repressed by E2F6 in blastocysts (Fig. 5a), even

























































GFP E2F6-WT E68 MB4
E2f6-/- ESCs transfected with
IgG
E2F1











GFP E2F6-WT E68 MB4WT
ESCs E2f6-/- ESCs transfected with
IgG
E2F6














GFP E2F6-WT E68 MB4





























































Fig. 4 E2F6 function requires the DNA-binding and marked box domains. a Schematic representation of the E2F6 protein and the mutants generated in the
study. The E68 mutant contains a point mutation in the DNA-binding domain. DBD: DNA-binding domain; LZ: leucine zipper; MB: marked box; HA: HA tag.
b E2F6 expression detected by western blotting with an anti-HA antibody in E2f6−/− ESCs rescued with an empty vector (GFP), E2F6 WT, E68 mutant or
MB4 mutant. c RT-qPCR analysis of Tuba3a expression (left) and ChIP-qPCR analysis of E2F6 binding in the Tuba3a promoter (right) in WT ESCs and E2f6−/−
ESCs rescued with an empty vector (GFP), E2F6-WT, E68 mutant or MB4 mutant. Tuba3a expression is represented as a percentage of expression relative to
the GFP control (expression normalized to Actb). For ChIP experiments, the values for the E2F6 ChIP and IgG control are shown for each condition. All values
are mean ± SEM (n= 3 experiments). d Metaplots showing E2F6 and E2F1 ChIP-seq read densities in E2F6 peaks linked to gene promoters bound but not
repressed by E2F6 (top, n= 1378 genes) or promoters of germline genes bound and repressed by E2F6 (bottom, n= 24 genes). On the right are shown
examples of E2F6 and E2F1 ChIP-seq profiles for the E2F cell cycle target gene Rrm1 and the E2F6-repressed gene Tuba3a. e ChIP-qPCR analysis of E2F1
binding in the Tuba3a promoter in WT ESCs and E2f6−/− rescued ESCs (mean ± SEM, n= 3). f RT-qPCR analysis in E2f6−/− ESCs transduced with lentiviral
vectors expressing E2F6-WT, E2F6-DBD1, or E2F6-MB4. The expression levels are shown as a percentage relative to cells transduced with an empty vector
(mean ± SEM, n= 4, expression normalized to Actb). Source data are provided as a Source Data file.
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Fig. 5 E2F6 facilitates de novo DNA methylation of germline genes during development. a RT-qPCR analysis of the expression of E2f6 and two E2F6
target genes in WT and E2f6−/− blastocysts (mean ± SEM, n= 4 blastocysts, expression normalized to Rpl13a). p-values: two-tailed t-test. b RT-qPCR
analysis of E2F6 target genes in WT and E2f6−/− ESCs cultivated in 2i medium, represented as a fold change relative to WT (mean ± SEM, n= 3,
expression normalized to Gusb, Rpl13a, and Mrpl32). A western blot showing E2F6 expression in ESCs cultivated in serum or 2i conditions is shown above
the graph. c Metaplot showing the average percentage of CpG methylation measured by WGBS over RefSeq genes and 10 kb of flanking sequences in WT
and E2f6−/− E8.5 embryos. d Heatmap representing the percentage of CpG methylation measured by WGBS in the promoters (−500 to +500 bp from the
TSS) of E2F6 target genes in WT and E2f6−/− E8.5 embryos. The genes written in gray contain only an E2F6 motif in their promoter and the genes in black
contain an E2F6 and E-box motif. e Genome tracks of E2F6 ChIP-seq (ESCs), WGBS, and RNA-seq in E8.5 embryos over two E2F6 target genes.
Hypomethylated DMRs (hypoDMRs) are depicted by red rectangles. f Comparison of the changes in gene expression and promoter DNA methylation
(measured by WGBS in −500 to +500 bp from the TSS) in E2f6−/− compared to WT E8.5 embryos for all genes. The genes simultaneously
overexpressed (log2FC > 2) and hypomethylated (<−10%) are highlighted in red. g Quantification of DNA methylation in the Tuba3a promoter by
pyrosequencing in E2f6−/− ES cells rescued with an empty vector (GFP), E2F6-WT, or the E2F6-MB4 mutant. h Heatmap of RRBS methylation scores in
the promoter of E2F6 target genes in E8.5 embryo knockout for E2f6, Dnmt3a, or Dnmt3b3. Each column represents an independent embryo. i Co-
immunoprecipitation experiments to investigate the interaction between E2F6 and DNMT3B. Immunoprecipitation was performed with an anti-HA
antibody on nuclear extracts from control ESCs and ESCs expressing 3×HA-E2F6. Western blotting was performed on the input and immunoprecipitates
using anti-HA, anti-L3MBTL2, anti-DNMT3B, and anti-GLP antibodies. j ChIP-qPCR analysis of H3K4me3 levels in the promoters of Actin b, Tuba3a, and
Gpat2 in WT and E2f6−/− ES cells (mean ± SEM, n= 3). p-values: two-tailed t-test. Source data are provided as a Source Data file.
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(Supplementary Fig. 5a). To corroborate this finding, we mea-
sured the expression of E2F6 target genes in E2f6+/+ and E2f6−/−
ESCs grown in 2i conditions, which inhibits DNA methylation40.
Bisulfite sequencing confirmed that the promoters of E2F6 target
genes are hypomethylated in 2i ESCs (Supplementary Fig. 5b)
and E2F6 binding to germline genes is unchanged in 2i condi-
tions as shown by a recent E2F6 ChIP-seq in 2i ESCs41 (Sup-
plementary Fig. 5c, d). Despite strongly reduced DNA
methylation, germline genes remain repressed by E2F6 in 2i ESCs
(Fig. 5b). Furthermore, RNA interference-mediated inhibition of
E2f6 leads to increased expression of germline genes in Dnmts-
TKO ES cells that lack DNA methylation (Supplementary
Fig. 5e). Collectively, these results suggest that E2F6 initially
represses germline genes by mechanisms other than DNA
methylation in early embryonic cells.
Previous studies identified HDAC1/2 and G9a as interactants
of PRC1.623,24,32,42; however, we found no enrichment of
HDAC1/2 or G9a/GLP in the E2F6 interactome in ESCs
(Supplementary Data 3), consistent with other reports25,26,28.
Furthermore, almost all E2F6-repressed germline genes are not
derepressed in G9a KO ESCs43 (Supplementary Fig. 6a, b), and
E2F6 and G9a repress distinct sets of genes in mouse embryos44
(Supplementary Fig. 6c, d). In addition, most germline genes
repressed by G9a were not identified as bound by E2F6,
suggesting that they act in distinct pathways. Altogether, these
data indicate that E2F6 function is independent of G9a.
To identify potential epigenetic mechanisms of E2F6-mediated
repression, we examined which chromatin features distinguish
germlines genes repressed by E2F6 from the other genes bound
but not repressed by E2F6 in ES cells. This revealed that
H3K9me3 and the H3K9 methyltransferase SETDB145–47 are
specifically enriched in E2F6-repressed germline genes (Supple-
mentary Fig. 6e), suggesting a link between E2F6-mediated
repression and H3K9me3. To explore this possibility, we
performed ChIP experiments and observed that the H3K9me3
mark is strongly reduced at E2F6 target genes in 2i E2f6−/− ESCs
(Supplementary Fig. 6f). Furthermore, many E2F6-repressed
germline genes are overexpressed upon SETDB1 inactivation in
ESCs in 2i or serum conditions48,49 (Supplementary Fig. 6a, b).
This suggests that E2F6 represses germline genes in naive cells in
part by favoring H3K9me3 deposition.
E2F6 triggers DNA methylation of germline genes during
development. Next, we investigated whether E2F6 is required for
the deposition of DNA methylation at germline genes after
implantation by performing whole genome bisulfite sequencing
(WGBS) in E2f6+/+ and E2f6−/− E8.5 embryos (Supplementary
Fig. 7a). Although global genome methylation is unchanged in
E2f6−/− embryos (Fig. 5c), DNA methylation is specifically
reduced in the promoter of several E2F6 target genes (Fig. 5d, e
and Supplementary Fig. 7b). In total, WGBS identified 64 dif-
ferentially methylated regions (DMRs) in E2f6−/− compared to
E2f6+/+ embryos, including 33 hypomethylated DMRs corre-
sponding to many promoters of germline genes repressed by
E2F6 (Supplementary Data 6). The hypomethylated DMRs
colocalize with E2F6 ChIP-seq peaks and presumably reflect
direct effects of E2F6 in recruiting DNA methylation, in contrast
to hypermethylated DMRs that likely result from indirect effects
(Supplementary Fig. 7c). The hypomethylation of germline genes
was further validated by reduced representation bisulfite
sequencing (RRBS) and combined bisulfite restriction analysis
(COBRA) in independent embryos (Supplementary Fig. 7d–f).
Correlation of gene expression and promoter DNA methylation
changes showed that most genes derepressed in E2f6−/− embryos
undergo concomitant promoter DNA hypomethylation (Fig. 5f),
indicating that E2F6 function is tightly linked to DNA methyla-
tion. Furthermore, most germline genes repressed by E2F6 are
derepressed in Dnmt3a/b DKO embryos lacking de novo
methylation15 (Supplementary Fig. 7g, p= 5.28e− 26, hyper-
geometric test), demonstrating the importance of DNA methy-
lation for E2F6-induced repression in embryos. In line with our
previous results, germline genes containing only the E2F6 motif
(e.g., Tuba3a, Majin, Gpat2, Smc1b, and Meioc) show an almost
complete reduction of DNA methylation in E2f6−/− embryos,
whereas genes containing an additional E-box (Slc25a31, Hor-
mad1, Mael, and Tex12) show partial hypomethylation (Fig. 5d),
suggesting that MAX/MGA compensate the absence of E2F6 for
DNA methylation.
DNA hypomethylation of E2F6 target genes is also observed in
E2f6−/− ESCs cultivated in serum plus leukemia inhibitory
factor (LIF) (Supplementary Fig. 7e). Using this experimental
system, we analyzed DNA methylation of the Tuba3a gene in
E2f6−/− ESCs rescued with WT E2F6 or the MB4 mutant. WT
E2F6 efficiently restored Tuba3a DNA methylation but not the
MB4 mutant (Fig. 5g). This demonstrates that E2F6-induced
DNA methylation requires the E2F6 marked box domain.
To further investigate whether DNA hypomethylation persists
at later developmental stages, RRBS was performed in the brain,
muscle, and kidney of E2f6+/+ and E2f6−/− mice at 4 weeks of
age (Supplementary Data 1). Promoter DNA hypomethylation of
E2F6 target genes was detected in all organs at levels similar to the
ones seen in E8.5 embryos (Supplementary Fig. 7h), demonstrat-
ing that the lack of de novo methylation in E2f6−/− embryos is
not compensated throughout development.
To determine which DNMT mediates E2F6-dependent DNA
methylation, we compared RRBS methylation levels of E2F6
target genes in E2f6−/− embryos with embryos knocked out for
Dnmt3a or Dnmt3b3. E2F6 target genes are strongly hypomethy-
lated in Dnmt3b−/− but not Dnmt3a−/− embryos (Fig. 5h),
suggesting that DNMT3B is the main enzyme depositing DNA
methylation at E2F6 target genes. Interestingly, DNMT3B is only
slightly enriched in the E2F6 interactome below the threshold of
significance (Supplementary Fig. 8) and we could not detect an
E2F6–DNMT3B interaction by western blotting analysis of co-
immunoprecipitation in ES cells (Fig. 5i). MS also did not reveal
an interaction between E2F6 and DNMT3A, DNMT1, or UHRF1
(Supplementary Fig. 8). This suggests that E2F6 does not
stimulate DNA methylation by direct interaction with the DNA
methylation machinery. We then investigated whether E2F6
could indirectly influence DNA methylation by regulating H3K4
methylation. We found that germline genes repressed by E2F6
have low levels of promoter H3K4me3 compared to other genes
bound but not repressed by E2F6 in ES cells (Supplementary
Fig. 6e). Furthermore, E2F6 target genes Tuba3a and Gpat2 show
elevated levels of promoter H3K4me3 in E2f6−/− ES cells (Fig. 5j),
suggesting that E2F6 could stimulate DNA methylation indirectly
by maintaining low levels of H3K4 methylation.
Altogether, these results demonstrate that E2F6 is indispen-
sable for promoting DNA methylation-dependent silencing to its
target genes during embryonic development, apparently through
indirect recruitment of DNMT3B.
E2F6 is dispensable for the maintenance of epigenetic silencing
in differentiated cells. The general view is that CGI DNA
methylation is not an initiating event in gene silencing but acts to
lock in the silent state for long-term silencing. We thus speculated
that E2F6 is required to initiate epigenetic silencing in early
development but not to maintain it in differentiated cells. To test
this hypothesis, we performed ectopic inactivation of E2f6 by
CRISPR-Cas9 in mouse embryonic fibroblasts (MEFs) and
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compared these cells to constitutive E2f6-KO MEFs derived from
E2f6−/− embryos (Fig. 6a). It was previously shown by ChIP that
E2F6 binds to the promoters of germline genes in MEFs22.
CRISPR-Cas9-mediated KO of E2f6 was performed by removing
the exon 3 or exon 4, which creates a frameshift resulting in
premature stop codons (Supplementary Fig. 9a). The inactivation
of E2f6 was validated by western blotting and RT-qPCR in two
independent E2f6-KO clones for each condition (Fig. 6b and
Supplementary Fig. 9b). E2f6-deficient MEFs generated by
CRISPR-Cas9 did not reactivate E2F6 target genes, in contrast to
MEFs derived from E2f6−/− embryos that showed a strong
derepression of germline genes (Fig. 6c). Furthermore, RRBS
showed that DNA methylation of E2F6 target genes is unaffected
in CRISPR-Cas9 E2f6-deficient MEFs (Fig. 6d). In contrast to
MEFs, ectopic inactivation of E2f6 by CRISPR-Cas9 in ESCs leads
to derepression of germline genes (Supplementary Fig. 9c–e). To
corroborate this finding in vivo, we monitored E2F6 expression
after birth and observed that the E2F6 protein becomes barely
detectable in various organs at 4 weeks of age compared to ES
cells (Supplementary Fig. 9f). Despite no detectable E2F6, the
silencing of germline genes is maintained in the liver and kidney
(Supplementary Fig. 9g), further suggesting that the continuous
presence of E2F6 is not required for the silencing of germline
genes in organs. Altogether, these results demonstrate that E2F6
is necessary to initiate epigenetic silencing of germline genes in
early embryonic cells but is no longer required for the main-
tenance of silencing in differentiated cells.
To examine whether the silencing of germline genes can be
rescued by E2F6 in differentiated cells, MEFs derived from E2f6−/−

























































































































































































































Fig. 6 E2F6 is dispensable for the maintenance of epigenetic silencing. a Experimental design. We either derived MEFs fromWT and E2f6−/− embryos or
generated E2f6-KO clones and WT control clones by CRISPR-Cas9. b Western blotting of E2F6 in MEFs derived from WT and E2f6−/− embryos and MEFs
CRISPR-Cas9 clones. β-ACTIN was used as a loading control. c RT-qPCR analysis of the expression of E2F6 target genes in embryo-derivedWT and E2f6−/−
MEFs (top), and MEF CRIPSR-Cas9 clones (bottom) (mean fold change compared to WT controls, n= 2 independent cell lines or clones per condition,
expression normalized to Gusb, Rpl13a, and Mrpl32). d Heatmap representing the percentage of CpG methylation profiled by RRBS in the promoters of E2F6
target genes in embryo-derived WT and E2f6−/− MEFs (left), and MEF CRISPR-Cas9 clones (right). e Western blotting of E2F6 in WT and E2f6−/− MEFs,
and E2f6−/− MEFs transduced with lentiviruses expressing E2F6 or E2F6 E68 fused to 3×-HA. α-TUBULIN was used as a loading control. f RT-qPCR analysis
of the expression of E2F6 target genes in WT and E2f6−/− MEFs, and E2f6−/− MEFs rescued with E2F6. The values are represented as the fold change
compared to WT (mean ± SEM, n= 3 independent experiments, expression normalized to Gusb, Rpl13a, andMrpl32). *p < 0.05, **p < 0.01, ns: not significant
(two-tailed t-test compared to E2f6−/− cells). gMethylation analysis by COBRA of the Tuba3a and Gpat2 promoters in WT and E2f6−/− MEFs, and E2f6−/−
MEFs rescued with E2F6. h Model: E2F6 binds to and represses promoters of germline genes in preimplantation stages. At implantation, E2F6 recruits DNA
methylation and initiates long-term epigenetic silencing of its target germline genes and subsequently becomes dispensable for the maintenance of the
epigenetic repression in differentiated cells. Source data are provided as a Source Data file.
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E2F6 or E2F6 mutated in the DNA-binding domain (Fig. 6e).
Restoring E2F6 expression in E2f6−/− MEFs significantly reduced
the expression of E2F6 target genes but was unable to restore
efficient silencing at most tested targets (Fig. 6f). Furthermore,
restoring E2F6 expression did not induce DNA methylation of the
E2F6 target genes Tuba3a and Gpat2 (Fig. 6g). The inability of
E2F6 to induce DNA methylation in MEFs might be due to the
near absence of DNMT3B in these cells (Supplementary Fig. 9h).
Taken together, our results show that E2F6 is required to
initiate stable epigenetic silencing of germline genes at a precise
developmental window during early embryogenesis and subse-
quently becomes dispensable for maintaining the repressed state
at later stages (Fig. 6h).
Discussion
Genome-wide studies of DNA methylation during embryonic
development revealed that CGI promoters are constitutively
protected from DNA methylation, whereas de novo DNA
methylation is specifically targeted to a small subset of promoter
CGIs of germline genes1–3. However, the molecular pathways
explaining this remarkable specificity are unknown. In this study,
we extend previous work on the role of the transcription factor
E2F620–22,36 and provide evidence that E2F6 is critical to promote
DNA methylation and initiate lifelong epigenetic silencing of a
subset of germline genes during mouse development.
Using genetic inactivation in mouse ES cells and in vivo, we
demonstrate that E2F6 is critical to silence a subgroup of germ-
line genes. E2F6 is a known DNA-binding component of the
PRC1.6 complex; however, our results suggest that E2F6-
dependent repression of germline genes is in part independent
of PRC1.6 recruitment. Thus, E2F6 has both PRC1.6-dependent
and -independent functions. In line with our results, a recent
study showed that MAX induces epigenetic repression of germ-
line genes in ESCs by PRC1-independent mechanisms50.
An important question is why E2F6-mediated repression is
restricted to a small subset of E2F6-bound promoters associated
with germline genes. Germline genes contain canonical E2F6-
binding motifs20 but these are not specific for germline genes and
occur in 2153 out of 2533 E2F6 ChIP-seq peaks. Therefore, the
specificity of E2F6-mediated repression is more complex than
simple DNA motif recognition. It has been shown previously for
E2F and AP-1 TFs that their target specificity resides outside their
DNA-binding domain38,51. In line with that, we demonstrated
that the repressive function of E2F6 at germline genes depends on
its marked box, a conserved domain that acts as a key determi-
nant of target gene specificity in E2F TFs38. The marked box
domain is not required for E2F recruitment to chromatin52 but
mediates protein–protein interactions27. We speculate that the
E2F6 marked box domain could mediate local interaction with
cofactors at the sites of germline promoters, which would escape
detection in our interactome analysis.
Our developmental study showed that E2F6 has a dual func-
tion as follows: (1) it represses its target genes during the global
hypomethylation phase in preimplantation stages and (2) it is
essential to recruit DNA methylation during global genome de
novo methylation at implantation, thus favoring a transition from
DNA methylation-independent to DNA methylation-dependent
repression of germline genes in development. The molecular basis
for the E2F6 dependency of DNA methylation deserves further
investigation. In a previous publication, an E2F6–DNMT3B
interaction was described by overexpression in human HEK293
cells and in MEFs22. However, we were unable to detect a strong
interaction between E2F6 and DNMT3B in mouse ES cells.
Furthermore, to our knowledge, MS analysis of E2F6-containing
PRC1.6 complexes so far failed to detect DNMT3A or
DNMT3B23,24,26. Overall, this does not support a direct recruit-
ment of DNMT3 by interaction with E2F6. Instead, we favor the
hypothesis that E2F6 indirectly facilitates DNA methylation
deposition. E2F6-dependent H3K9me3 could recruit DNA
methylation, which is consistent with SETDB1 being required for
DNA methylation of germline genes in mouse ES cells53. Alter-
natively, increasing evidence supports the view that H3K4me3
and activating TFs play a key role in the protection of CGIs
against DNA methylation7–10,13. Interestingly, we demonstrated
that, whereas the majority of genomic E2F6 targets are bound by
E2F6 and E2F1, E2F6 has the unique ability to preclude binding
of E2F1 to germline genes. Therefore, E2F6 could override the
intrinsic protection of CGIs against DNA methylation at germline
genes by opposing transcriptional activators such as E2F1 and
H3K4me3 deposition. E2F1 was previously linked to the protec-
tion against DNA methylation in oogenesis54. Future work should
be aimed at testing these hypotheses.
Some E2F6 target genes are only partially hypomethylated in
E2f6−/− embryos, suggesting that other pathways cooperate with
E2F6 for DNA methylation recruitment at germline genes. As
these genes contain promoter-proximal E-boxes, it is likely that
E2F6 and MAX/MGA cooperate to induce epigenetic silencing of
germline genes. In support of this model, DNA methylation of
several germline genes is compromised in MAX-knockdown
ESCs50. Unfortunately, the inability to maintain Mga−/− ESCs
and the early lethality of Mga and Max KO embryos at pre-
and peri-implantation stages55,56 precludes a detailed study of
the role of MAX/MGA in the epigenetic regulation of
germline genes.
Once initiated, the epigenetic silencing of germline genes is
stable and does not require the continued presence of E2F6. DNA
methylation is a well-defined epigenetic mark mediating long-
lasting gene repression and is one prime mediator of E2F6-
induced stable silencing. Indeed, most of the E2F6 target genes
are upregulated in DNA methylation-deficient embryos. How-
ever, our data suggest that E2F6 also induces long-term silencing
of germline genes by other mechanisms than DNA methylation.
Some target genes such as Smc1b and Meioc acquire only partial
promoter CGI methylation and are much more derepessed in
E2f6−/− embryos compared to Dnmt3a/b mutant embryos, sug-
gesting that E2F6 induces long-term repression of germline
genes through multiple epigenetic functions. These alternative
mechanisms could involve polycomb-mediated H3K27 methyla-
tion, which is involved in silencing of the Smc1b gene in mouse
ESCs57.
Our study contributes to explain how epigenetic repression is
targeted with remarkable specificity to germline genes during
embryonic development, providing a paradigm for how transient
repressive signals by DNA-binding factors are translated into
lifelong repressive epigenetic signals. This is reminiscent of
KRAB-ZFPs TFs establishing stable epigenetic repression of TEs
in development58, suggesting potential evolutionary convergences
between the mechanisms that restrict expression of potentially
harmful transposons and germline genes in mammalian
somatic cells.
Methods
Mouse lines. The E2f6-KO mouse line37 was a gift from Jacqueline Lees (Cam-
bridge, MA). Heterozygous mice were maintained in a C57BL/6J background and
E2f6−/− animals were generated by mating heterozygous males and females. We
used WT embryos from the same litters as controls. The morning of the vaginal
plug was designed as E0.5. and embryos were dissected at E8.5 in M2 medium.
Postnatal organs were collected at 4 weeks of age. Animal experimental procedures
complied with the ethical regulations of the Comité d’Ethique Régional en
Expérimentation Animale de Strasbourg (CREMEAS). Mice were housed with free
access to food and water, a 12 h light/dark cycle, and controlled temperature
(20–24 °C) and humidity (40–70%).
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ES cells. E2f6−/− and E2f6+/+ ESCs were established from blastocysts of E2f6−/−
and control mice21. These cells were cultured on gelatin-coated plates in KO
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% KO serum
replacement, 5% fetal calf serum (Pan Biotech), 1000 U/mL LIF, 1× non-essential
amino acids, 2 mM GlutaMAX, 1% penicillin/streptomycin, and 0.1 mM 2-
mercaptoethanol. ESCs were adapted in 2i conditions in DMEM F12 medium
supplemented with 50% Neurobasal medium, 1× N2 (Thermo Fisher Scientific), 1×
B27 (Thermo Fisher Scientific), 2 mM L-Glutamine, 1% penicillin/streptomycin,
0.1 mM 2-mercaptoethanol, 0.5% bovine serum albumin (Merck), 1000 U/mL LIF,
1 µM PD0325901 (Merck), 3 µM Chir99021 (Merck), and 100 µg/mL Ascorbic
Acid (Sigma). ES cells were cultured in 2i medium for 14 days. ES cells E14TG2a
were cultured on gelatin-coated plates in DMEM GlutaMAX medium supple-
mented with 15% fetal bovine serum (FBS), 1000 U/mL LIF, 0.1 mM non-essential
amino acids, 2 mM L-Glutamine, 1% penicillin/streptomycin, and 0.1 mM 2-
mercaptoethanol. J1 WT and J1 Dnmt-TKO ES cells were a gift from M. Okano59.
These cells were cultured on gelatin-coated dishes in DMEM Glutamax supple-
mented with 15% FBS, 1000 U/mL LIF, 0.1 mM non-essential amino acids, 1 mM
sodium pyruvate, 50 U/mL penicillin/streptomycin, and 0.1 mM 2-
mercaptoethanol. ESCs were passaged with Trypsin-EDTA 0.25% (Thermo Fisher
Scientific) every 2 days. All ESCs were tested negative for mycoplasma
contamination.
E2f6 knockdown by siRNA. J1 WT and J1 Dnmt-TKO ES cells were transfected
with ON-TARGETplus SMART pool small interfering RNAs (siRNAs) (Horizon
Discovery, non-targeting pool # D-001810-10 and E2f6 # L-047927) using Lipo-
fectamine 2000 (Thermo Fisher Scientific). Lipofectamine 2000 (10 µL) and 0.5 mL
DMEM were mixed with 200 pmol siRNA and 0.5 mL DMEM, and kept at room
temperature (RT) for 20 min. The mix was added to a suspension of 1 mL of mESC
(160 K cells/mL) in serum medium and plated on a 60 mm diameter petri dish. The
medium was changed 6 h later and renewed every 24 h. Cells were collected 72 h
after transfection for nucleic acid extraction. Target sequences for E2f6: 5′-
GUUUAUGGAUCUCGUCAGA-3′/5′-CACAUUAGGUGGAUAGGAU-3′/5′-
GUAUGUAACCUAUCAGGAU-3′/5′-UAAACAAAGUUGCCACAAA-3′.
Isolation and culture of MEFs. MEFs were isolated from E13.5 E2f6−/− and WT
embryos. Primary fibroblasts were immortalized by infecting cells with retroviruses
encoding the Antigen T produced in HEK293 cells with the plasmid pBABE-neo
largeTcDNA (Addgene #1780). MEFs were grown in DMEM supplemented with
10% FBS and 1% penicillin/streptomycin in a humidified atmosphere containing
5% CO2 at 37 °C. MEFs were passaged every 3 days and were tested negative for
mycoplasma contamination.
Inactivation of E2f6 by CRISPR-Cas9. E2f6-KO cells were generated by deleting
either the exon 3 or the exon 4 using two guide RNAs (gRNAs) flanking the exon.
The gRNAs around exon 3 (gRNA1: 5′-CCCTCATTACTTCAGGATTG-3′;
gRNA2: 5′-TAGTGCTGCCACTGCGCTAA-3′) and exon 4 (gRNA1: 5′-CTGA
GAAATGTCGGTTCACA-3′; gRNA2: 5′-CATGGTGTGGAAAACTTAAC-3′)
were designed using http://crispr.mit.edu. The gRNAs were cloned in the CRISPR-
Cas9 plasmids PX458 (pSpCas9(BB)-2A-GFP, Addgene #48138) and PX459
(pSpCas9(BB)-2A-Puro, Addgene #62988). Immortalized MEFs were transfected
by the PX458 plasmid using the Neon electroporation system (Thermo Fisher
Scientific). Cells expressing green fluorescent protein (GFP) were selected 24 h post
transfection by flow cytometry and plated at a clonal density in 96-well plates.
Mouse ESCs E14TG2a (obtained from ATCC, CRL-1821) were transfected by the
PX459 plasmid using Lipofectamine transfection reagent (Invitrogen) and selected
for 72 h by Puromycin (2 µg/mL). Single ES colonies were selected and plated in
96-well plates. The clones were genotyped by PCR on genomic DNA isolated with
the AllPrep DNA/RNA Mini Kit (Qiagen) using primers in the exon 3 or exon 4.
We selected WT and E2f6-KO clones that were further validated by Sanger
sequencing, western blotting, and RT-qPCR using primers spanning the exons 3
and 4 (provided in the Supplementary Data 7). For western blotting, whole cell
extracts were prepared in RIPA lysis buffer (Clinisciences).
shRNA knockdown of MGA and MAX in ES cells. Lentiviral shRNA knockdown
constructs were generated by cloning synthetic oligos corresponding to MGA
shRNA (TRCN0000082083), MAX shRNA (TRCN0000039867), and scramble
control of the Genetic Perturbation Platform (Broad Institute) into the pLKO.1
puro shRNA expression vector (Addgene #8453). Knockdown was performed by
infecting E2f6+/+ or E2f6−/− ESCs with lentiviral particles produced in
HEK293T cells in the presence of 8 μg/ml polybrene. Twenty-four hours after
transduction, ESCs were selected with puromycin (2 μg/ml) and RNA was collected
after 48 h of selection.
Expression vectors for ES cells. For stable transfection experiments in ESCs, the
sequences coding for E2F6 WT, as well as E68 and MB4 mutants, were inserted
into the pCAG-EGFP-IB vector60. To generate the E68 DNA-binding mutant, the
amino acids in positions 68 and 69 were changed from Leu-Val to Glu-Ser18. To
generate the MB4 mutant, the E2F6 marked box domain (aa 180–240) was replaced
by the marked box domain of E2F4 (aa 138–198). These constructs were
transfected into ESCs by electroporation with the Amaxa Nucleofector II device
using the Amaxa Cell Line Nucleofector kit R and stable transfectants were selected
with blasticidin (7.5 μg/ml). For the DNA-binding domain swap experiment, the
sequences coding for E2F6 WT, DBD1, and MB4 mutants were inserted in the
lentiviral expression vector pCDH-MSCV-MCS-EF1α-GFP+ Puro (System Bios-
ciences). The DBD1 mutant was generated by replacing the DNA-binding domain
of E2F6 (aa 61–129) with the DNA-binding domain of E2F1 (aa 122–187). Viral
particles were produced in HEK293T cells and ESCs were infected with 8 μg/ml
polybrene. Twenty-four hours after transduction, puromycin (2 μg/ml) was added
for 72 h before collecting the RNA samples.
Expression vectors for MEFs. The sequences coding for E2F6 WT and E68 fused
to 3×-HA were cloned into the pMSCV Puro-IRES-GFP retroviral vector (Addgene
#21654) with the In-Fusion HD cloning plus kit (Takara). Viral particles produced
in HEK293T cells were used to infect immortalized E2f6−/− MEFs with 8 μg/ml
polybrene. Twenty-four hours after infection, the cells were selected with Pur-
omycin (2 μg/ml) for 48 h. The cells were collected 14 days after the infection for
protein, DNA, and RNA extraction.
Co-immunoprecipitation experiments. ES cell line E14TG2a was transfected with
the pCAG-3×HA-E2F6 vector and selected with blasticidine at 0.01 µg/µL until
stable integration of the plasmid. Nuclear extract (1 mg) was incubated with anti-
HA magnetic beads (Pierce) overnight at 4 °C. The complex bead–proteins was
washed in a buffer containing 15 mM of Tris pH 8, 150 mM NaCl, 0.05% Triton.
Proteins were eluted in Laemmli buffer (Thermo Fisher Scientific). As a control,
immunoprecipitation was performed on E14TG2a cells not expressing 3×HA-
E2F6. Twenty-five percent of eluted proteins and 15 µg of input proteins were
loaded on a 10% SDS-polyacrylamide gel and assessed by western blotting.
Interactome analysis by mass spectrometry. Immunoprecipitations were carried
out on 1 mg of nuclear extract from 3×HA-E2F6 and control E14TG2a cells with
mMACS anti-HA microbeads (Miltenyi Biotec) according to the manufacturer’s
protocol. Protein complexes were eluted out of the magnetic stand with the SDS
gel-loading buffer from the kit and eluted proteins were precipitated overnight with
five volumes of cold 0.1 M ammonium acetate in 100% methanol before being
digested with sequencing-grade trypsin (Promega). Generated peptides were ana-
lyzed by nanoscale liquid chromatography-MS/MS on a QExactive Plus mass
spectrometer coupled to an EASY-nanoLC-1000 (Thermo Fisher Scientific) and
they were identified with the Mascot algorithm (version 2.5, Matrix Science) using
the Swissprot database with the Mus musculus taxonomy (release 2019_10) and the
software’s decoy strategy. Mascot identifications were imported into the Proline
software61 v1.4 where they were validated using the following settings: Mascot
pretty rank equal to 1 and 1% false discovery rate on both peptide spectrum
matches (PSM score) and protein sets (Protein Set score). The total number of MS/
MS fragmentation spectra was used to quantify each protein. For the statistical
analysis of the data, we compared the co-immunoprecipitation data collected for
3×HA-E2F6 samples against the negative controls using R v3.5.0. The spectral
counts were normalized with DESeq2 (median of ratios method) and EdgeR was
used to perform a negative-binomial test and calculate the fold change, p-value, and
adjusted p-value corrected by Benjamini–Hochberg for each protein. We identified
statistically enriched protein partners with a fold change >2 and an adjusted p-
value < 0.05.
ChIP of E2F6, E2F1, PRC1.6, and histone modifications. ESCs were crosslinked
in phosphate-buffered saline (PBS) with 1% formaldehyde for 15 min on ice and
quenched with 125 mM glycine for 5 min. Cells were lysed in 50 mM Tris pH 8,
10 mM EDTA, 1% SDS with 1× cOmplete Mini protease inhibitor cocktail (Sigma
Aldrich) and sonicated with a Bioruptor (Diagenode) at 4 °C. Eighty micrograms of
chromatin were used per ChIP reaction and incubated with antibodies pre-bound
to Dynabeads protein G (Thermo Fisher Scientific) overnight at 4 °C. The following
antibodies were used: E2F6 (ab53061, Abcam), PCGF6 (24103-1-AP, Proteintech),
RYBP (AB3637, Millipore), E2F1 (C-20, Santa Cruz Biotechnology), H3K4me3
(003-050, Diagenode), and as control normal mouse IgG (12-371, Millipore). The
beads were washed successively in low-salt buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris pH 8, 150 mM NaCl), high-salt buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris pH 8, 500 mM NaCl), LiCl-buffer (0.25 M
LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris pH 8), and TE
(10 mM Tris pH 8, 1 mM EDTA). Bound chromatin was eluted with elution buffer
(1% SDS, 0.1 M NaHCO3) and crosslinking was reverted at 62 °C overnight in the
presence of proteinase K (Qiagen). DNA was purified with a PCR Purification Kit
(Qiagen). For ChIP of H3K9me3, ESCs were crosslinked in PBS with 1% for-
maldehyde for 10 min at RT and quenched with 125 mM glycine for 5 min. Cells
were lysed in a buffer containing 0.1% SDS, 1% Triton X-100, 1 mM EDTA, 50 mM
HEPES-KOH, 140 mM NaCl, 0.1% sodium deoxycholate, 1× protease inhibitor
cocktail (Santa Cruz). The chromatin was sonicated with a Bioruptor (Diagenode)
at 4 °C. Antibodies were pre-bound to protein A-coated magnetic beads (Diag-
enode) and incubated overnight at 4 °C with chromatin from 200,000 cells per
ChIP reaction. We used antibodies against H3K9me3 (ab8898, Abcam), H3 (07-
690, Merck), and IgG2A as a control (MAB0031, R&D Systems). Chromatin was
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successively washed in three buffers containing 0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris pH 8, 150 mM NaCl, then 0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris pH 8, 500 mM NaCl and 0.25 M LiCl, 1% NP40, 1% sodium
deoxycholate, 10 mM Tris pH 8, 1 mM EDTA. Chromatin was decrosslinked for 4
h at 65 °C and then treated with proteinase K (Euromedex) for 1 h at 56 °C. DNA
was isolated by phenol–chlorofom extraction and ethanol precipitation for qPCR
analysis. The primers are provided in the Supplementary Data 7.
ChIP-seq analysis. ChIP-seq libraries of E2F6 ChIP and input samples were
prepared from E2f6+/+ and E2f6−/− ESCs using the DNA sample kit (Illumina)
following the manufacturer’s instructions. After adapter ligation, the DNA was
PCR amplified with Illumina primers for 15 cycles and library fragments of ~250
bp were band isolated from an agarose gel. Libraries were sequenced in single-end
1 × 50 bp with an Illumina HiSeq 1500. For all ChIP-seq datasets used in the study,
reads were trimmed using Trim Galore v0.4.4, aligned to the mouse genome
assembly mm10 using bowtie2 v2.3.0, and only reads with a mapping quality above
10 were kept. Read density tracks were generated using genomeCoverageBed from
bedtools, from reads extended to 200 bp and visualized using the IGV browser.
Peaks were called using Peakzilla with default settings. The analysis of motif
enrichment and distribution of motifs in peaks was performed using
TFmotifView62. Briefly, control regions were selected randomly within the same
chromosome from regions with matched CpG content within DNase open-
chromatin regions. E2F6 peak regions (150 bp around peak summits) and shuffled
control regions were searched for motif occurrences using MAST v5.1.0 (from the
MEME suite) with a dynamic p-value threshold based on the motif information
content (IC) (p-value= 1/2IC). The statistical significance of the motif enrichment
in peaks over control regions was assessed using a hypergeometric p-value. The
overlap of E2F6 peaks with CGIs was done by intersecting peak summits with the
CGI annotation downloaded from the UCSC mm10 reference genome. For each
E2F6 peak summit, the distance to their closest TSS was calculated using the UCSC
Refseq annotation. To identify E2F6-bound gene promoters, we selected the genes
corresponding to E2F6 peak summits distant <500 bp from their closest Refseq
TSS. GO analysis of E2F6-bound promoters was performed using DAVID v6.8.
Average ChIP-seq signals around E2F6 peak summits were calculated using bwtool
v1.0. The pairwise correlation of ChIP-seq read densities was calculated by merging
both peak regions with mergedBed from bedtools, extracting the maximum read
density for both samples using bwtool summary, and their correlation was
represented using the aheatmap function from the NMF package v0.21.0 in R. The
overlap of E2F6, MGA, and L3MBTL2 peaks was generated with the findO-
verlapsOfPeaks function from the ChIPpeakAnno package v3.18.2 in R with a
maximum gap of 500 bp. The datasets used for ChIP-seq analysis are described in
the “Data availability” statement. For these datasets, raw reads were processed
using the same pipeline as for E2F6.
Transcriptome analysis by RNA-seq. RNA-seq was performed on three inde-
pendent cultures of ES cell lines and three single WT and E2f6−/− embryos col-
lected from the same litters. RNAs from ESCs were extracted using the RNeasy kit
(Qiagen). For embryos, we simultaneously prepared genomic DNA and total RNA
from whole single embryos with the AllPrep DNA/RNA Mini Kit (Qiagen). RNA
quality was verified on a 2100 Bioanalyzer (Agilent). RNA-seq libraries were
generated from 250 ng of total RNA using the TruSeq Stranded Total RNA Library
Prep kit with Ribo-Zero depletion (Illumina) according to the manufacturer’s
instructions, and sequenced in paired-end 2 × 100 bp on an Illumina HiSeq4000.
Reads were mapped using TopHat v2.0.13 with a RefSeq transcriptome index and
counted in RefSeq genes with HTSeq v0.7.2 (parameters –t exon –s reverse).
Differentially expressed genes were identified using DESeq2 (fold change >3,
adjusted p-value < 0.0001). Genes from the Y chromosome were excluded. GO
analysis was performed with DAVID 6.8 (https://david.ncifcrf.gov). We also used
published RNA-seq datasets, which are described in the “Data availability”
statement.
Methylome analysis by RRBS and WGBS. RRBS libraries were prepared by MspI
digestion from 50 to 100 ng genomic DNA44 and sequenced in paired-end 2 × 75
bp on an Illumina HiSeq4000 at Integragen SA (Evry, France). We trimmed RRBS
reads to remove low-quality bases with Trim Galore v0.4.2 and aligned reads to the
mm10 genome with BSMAP v2.74 (parameters -v 2 -w 100 -r 1 -x 400 -m 30 -D C-
CGG -n 1). We calculated methylation scores using methratio.py in BSMAP v2.74
(parameters -z -u -g) and filtered CpGs covered by a minimum of eight reads. For
WGBS, 100 ng genomic DNA was fragmented to 350 bp using a Covaris
E220 sonicator and bisulfite-converted with the EZ DNA Methylation-Gold kit
(Zymo Research). WGBS libraries were prepared using the Accel-NGS Methyl-Seq
DNA Library Kit and the Methyl-Seq Set A Indexing Kit (Swift Biosciences)
according to the manufacturer’s instructions, with six PCR cycles for the final
amplification. The libraries were purified using Ampure XP beads (Beckman
Coulter) and sequenced in paired-end 2 × 100 bp with an Illumina HiSeq4000 at
Integragen SA (Evry, France). The reads were trimmed to remove low-quality bases
and the first five bases of reads R1 and ten bases of reads R2 using Trim Galore
v0.4.2 (parameters -q 20 --clip_R1 5 --clip_R2 10), and aligned to the mouse mm10
genome using Bismark v0.18.2 with default parameters. Methylation calls were
extracted using Bismark v0.18.2 and only CpGs covered by more than five reads
were retained for analyses. Metaplots of methylation over genes were generated by
calculating the percentage of CpG methylation in 20 equal-sized windows within
each RefSeq gene and ten 1 kb windows of flanking sequences. DMRs were iden-
tified using eDMR from the methylKit R package with a minimum of seven dif-
ferentially methylated CpGs, a difference in methylation >20% and a q-value <
0.001.
COBRA and bisulfite sequencing. Genomic DNA (100 ng) was bisulfite-
converted with the EpiTect bisulfite kit (Qiagen). The target regions were amplified
by touchdown PCR with the Platinum Taq DNA Polymerase (Thermo Fisher
Scientific) using the following conditions: 20 cycles of 30 s at 95 °C, 30 s at 60–50 °C
(with a 0.5 °C decrease per cycle), 50 s at 72 °C followed by 35 cycles of 30 s at
95 °C, 30 s at 50 °C, and 50 s at 72 °C. The PCR products were purified using the
PCR cleanup kit (Macherey Nagel). For COBRA, 40 ng of PCR product were
digested by Taq1α (Thermo Fisher Scientific) and loaded on an agarose gel
alongside 40 ng of undigested PCR product. For bisulfite sequencing, the PCR
products were cloned by TA cloning in the pCR2.1 vector (Thermo Fisher Sci-
entific) and sequenced by Sanger sequencing (Eurofins). Sequences were aligned
with the BISMA software and filtered to remove identical clones. The primers are
provided in the Supplementary Data 7.
Pyrosequencing. Genomic DNA was bisulfite-converted with the EpiTect bisulfite
kit (Qiagen). The target region was amplified by PCR using the ZymoTaq PreMix
(Epigenie) and pyrosequencing was performed by Varionostic (Ulm, Germany).
The primers are provided in the Supplementary Data 7.
Reverse-transcriptase quantitative PCR. Total RNAs were reverse transcribed
into cDNA with the Maxima first strand cDNA synthesis kit (Thermo Fisher
Scientific). qPCR was performed with the KAPA SYBR FAST qPCR kit (KAPA
Biosystems) on a StepOnePlus realtime PCR system (Applied Biosystems). The
expression of target genes was normalized with several housekeeping genes (B2m,
Actin b, Gusb, Rpl13a, or Mrpl32) as indicated in the figure legends. No-RT con-
trols were tested to exclude the presence of contaminating DNA. The primer
sequences for qPCR are provided in the Supplementary Data 7.
Gene expression analysis in single blastocysts. Blastocysts were isolated from
uterine tubes in M2 medium and washed in PBS 1× droplets. Single blastocysts
were collected in microtubes in 30 µL of H2O supplemented with RNase inhibitor
(Promega) and lysed by performing five rounds of freezing in liquid nitrogen and
thawing at 37 °C for 5 min. RNAs were reverse transcribed into cDNA with the
Maxima first strand cDNA synthesis kit (Thermo Fisher Scientific) for qPCR
analysis of target genes and Rpl13a as a normalization control. The blastocysts were
genotyped by expression of the E2f6 transcript. The primers are provided in the
Supplementary Data 7.
Western blotting. Proteins were run on SDS-polyacrylamide gels and transferred
to 0.2 µm nitrocellulose membranes using the Trans-blot Turbo Blotting System
(Biorad). The membranes were blocked with Tris Buffered Saline (TBS), 5% milk,
0.05% Tween for 1 h at RT, incubated with the primary antibodies and then with
horseradish peroxidase-conjugated secondary antibodies followed by chemilumi-
nescence detection using the ECL detection reagent (Amersham, GE Healthcare).
We used the following antibodies: E2F6 (Kerafast LLF6-2, 1 : 500), ACTB (Sigma
Aldrich A2066, 1 : 1000), α-TUBULIN (Sigma Aldrich T9026, 1 : 1000), β-
TUBULIN (Sigma Aldrich T8328, 1 : 1000), RYBP (Millipore AB3637, 1 : 1000),
L3MBTL2 (Active Motif 39570, 1 : 500), PCGF6 (Proteintech 24103-1-AP, 1 : 500),
MGA (Thermo Fisher Scientific PA5-59934, 1 : 500), RING1B (MBL D139-3, 1 :
1000), MAX (Santa Cruz Biotechnology sc-197, 1 : 200), GLP (R&D Systems PP-
B0422-00, 1 : 500), DNMT3B (Abcam ab13604, 1 : 250), and HA (Roche 3F10, 1 :
500).
Statistics and reproducibility. The experiments were repeated independently as
described in the figure legends. We performed five independent replicates for the
interactome analysis and three independent replicates for RNA-seq. In vivo mea-
surements were performed on independent animals. Western blottings were per-
formed at least twice with similar results and one representative image is shown in
the figures. Details on the statistical tests are given in the figure legends.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The RNA-seq, ChIP-seq, RRBS, and WGBS data generated in this study are available in
the NCBI Gene Expression Omnibus (GEO) under the accession number GSE149025.
The following published ChIP-seq datasets were used: KDM2B (GSM1272789), EZH2
(GSM1917297), SUZ12 (GSM1917296), RING1B (GSM1917298), G9a (GSM1215219),
RYBP (GSM1041375), PCGF6 (ERX2161380), L3MBTL2 (ERX2161378), MGA
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23596-w
12 NATURE COMMUNICATIONS |         (2021) 12:3582 | https://doi.org/10.1038/s41467-021-23596-w |www.nature.com/naturecommunications
(ERX2161379), MAX (GSM1171650), ZFX (GSM288352), E2F1 (GSM288349), CTCF
(GSM747534), TIP60 (GSM1183114), DMAP1 (GSM1183112), MYC (GSM1183111),
TET1 (GSM611192), HDAC2 (GSM687279), ESRRB (GSM288355), DAX1
(GSM1183116), OCT4 (ERX1965633), KLF4 (ERX1965624), NANOG (GSM288345),
SOX2 (GSM1910640), E2F6 in 2i conditions (GSM2907075), SETDB1 (GSM1893615,
GSM440256), H3K9me3 (GSM1893613, GSM1487056), and H3K4me3 (GSM1487054).
We also used RNA-seq datasets from G9a KO embryos (GSE71500), G9a KO ESCs
(GSE49669), and SETDB1 KO ESCs (GSE29413, PRJNA544540). The mass spectrometry
proteomics data have been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier PXD023974. We used the following
publicly available databases: UCSC genome annotations, Swissprot database. All relevant
data are available in the Supplementary Information files or from the corresponding
authors. The Source data for Figs. 1h, j, 2b, c, f, 3c–e, 4b, c, e, f, 5a, b, h, i, and 6b, c, e–g,
and Supplementary Figs. 2c, e, 4a–c, 5e, 6f, 7f, and 9c–h are provided with this paper in
the source data file.
Received: 14 July 2020; Accepted: 4 May 2021;
References
1. Borgel, J. et al. Targets and dynamics of promoter DNA methylation during
early mouse development. Nat. Genet. 42, 1093–1100 (2010).
2. Smith, Z. D. et al. A unique regulatory phase of DNA methylation in the early
mammalian embryo. Nature 484, 339–344 (2012).
3. Auclair, G., Guibert, S., Bender, A. & Weber, M. Ontogeny of CpG island
methylation and specificity of DNMT3 methyltransferases during embryonic
development in the mouse. Genome Biol. 15, 545 (2014).
4. Boulard, M., Edwards, J. R. & Bestor, T. H. FBXL10 protects Polycomb-bound
genes from hypermethylation. Nat. Genet. 47, 479–485 (2015).
5. Ooi, S. K. et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de
novo methylation of DNA. Nature 448, 714–717 (2007).
6. Li, B. Z. et al. Histone tails regulate DNA methylation by allosterically
activating de novo methyltransferase. Cell Res. 21, 1172–1181 (2011).
7. Eckersley-Maslin, M. A. et al. Epigenetic priming by Dppa2 and 4 in
pluripotency facilitates multi-lineage commitment. Nat. Struct. Mol. Biol. 27,
696–705 (2020).
8. Gretarsson, K. H. & Hackett, J. A. Dppa2 and Dppa4 counteract de novo
methylation to establish a permissive epigenome for development. Nat. Struct.
Mol. Biol. 27, 706–716 (2020).
9. Gebhard, C. et al. General transcription factor binding at CpG islands in
normal cells correlates with resistance to de novo DNA methylation in cancer
cells. Cancer Res. 70, 1398–1407 (2010).
10. Brandeis, M. et al. Sp1 elements protect a CpG island from de novo
methylation. Nature 371, 435–438 (1994).
11. Macleod, D., Charlton, J., Mullins, J. & Bird, A. P. Sp1 sites in the mouse aprt
gene promoter are required to prevent methylation of the CpG island. Genes
Dev. 8, 2282–2292 (1994).
12. Boumber, Y. A. et al. An Sp1/Sp3 binding polymorphism confers methylation
protection. PLoS Genet. 4, e1000162 (2008).
13. Krebs, A. R., Dessus-Babus, S., Burger, L. & Schubeler, D. High-throughput
engineering of a mammalian genome reveals building principles of
methylation states at CG rich regions. Elife 3, e04094 (2014).
14. Hackett, J. A. et al. Promoter DNA methylation couples genome-defence
mechanisms to epigenetic reprogramming in the mouse germline.
Development 139, 3623–3632 (2012).
15. Dahlet, T. et al. Genome-wide analysis in the mouse embryo reveals the
importance of DNA methylation for transcription integrity. Nat. Commun.
11, 3153 (2020).
16. Morkel, M., Wenkel, J., Bannister, A. J., Kouzarides, T. & Hagemeier, C. An
E2F-like repressor of transcription. Nature 390, 567–568 (1997).
17. Giangrande, P. H. et al. A role for E2F6 in distinguishing G1/S- and G2/M-
specific transcription. Genes Dev. 18, 2941–2951 (2004).
18. Gaubatz, S., Wood, J. G. & Livingston, D. M. Unusual proliferation arrest and
transcriptional control properties of a newly discovered E2F family member,
E2F-6. Proc. Natl Acad. Sci. USA 95, 9190–9195 (1998).
19. Trimarchi, J. M. et al. E. 2. F.-6., a member of the E2F family that can behave
as a transcriptional repressor. Proc. Natl Acad. Sci. USA 95, 2850–2855 (1998).
20. Kehoe, S. M. et al. A conserved E2F6-binding element in murine meiosis-
specific gene promoters. Biol. Reprod. 79, 921–930 (2008).
21. Pohlers, M. et al. A role for E2F6 in the restriction of male-germ-cell-specific
gene expression. Curr. Biol. 15, 1051–1057 (2005).
22. Velasco, G. et al. Dnmt3b recruitment through E2F6 transcriptional repressor
mediates germ-line gene silencing in murine somatic tissues. Proc. Natl Acad.
Sci. USA 107, 9281–9286 (2010).
23. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M. & Nakatani, Y. A
complex with chromatin modifiers that occupies E2F- and Myc-responsive
genes in G0 cells. Science 296, 1132–1136 (2002).
24. Qin, J. et al. The polycomb group protein L3mbtl2 assembles an atypical
PRC1-family complex that is essential in pluripotent stem cells and early
development. Cell Stem Cell 11, 319–332 (2012).
25. Hauri, S. et al. A high-density map for navigating the human polycomb
complexome. Cell Rep. 17, 583–595 (2016).
26. Trojer, P. et al. L3MBTL2 protein acts in concert with PcG protein-mediated
monoubiquitination of H2A to establish a repressive chromatin structure.
Mol. Cell 42, 438–450 (2011).
27. Trimarchi, J. M., Fairchild, B., Wen, J. & Lees, J. A. The E2F6 transcription
factor is a component of the mammalian Bmi1-containing polycomb complex.
Proc. Natl Acad. Sci. USA 98, 1519–1524 (2001).
28. Kloet, S. L. et al. The dynamic interactome and genomic targets of Polycomb
complexes during stem-cell differentiation. Nat. Struct. Mol. Biol. 23, 682–690
(2016).
29. Farcas, A. M. et al. KDM2B links the Polycomb Repressive Complex 1 (PRC1)
to recognition of CpG islands. Elife 1, e00205 (2012).
30. Endoh, M. et al. PCGF6-PRC1 suppresses premature differentiation of mouse
embryonic stem cells by regulating germ cell-related genes. Elife 6, e21064 (2017).
31. Hisada, K. et al. RYBP represses endogenous retroviruses and
preimplantation- and germ line-specific genes in mouse embryonic stem cells.
Mol. Cell Biol. 32, 1139–1149 (2012).
32. Maeda, I. et al. Max is a repressor of germ cell-related gene expression in
mouse embryonic stem cells. Nat. Commun. 4, 1754 (2013).
33. Stielow, B., Finkernagel, F., Stiewe, T., Nist, A. & Suske, G. MGA, L3MBTL2
and E2F6 determine genomic binding of the non-canonical Polycomb
repressive complex PRC1.6. PLoS Genet. 14, e1007193 (2018).
34. Zhao, W. et al. Essential role for polycomb group protein Pcgf6 in embryonic
stem cell maintenance and a noncanonical polycomb repressive complex 1
(PRC1) integrity. J. Biol. Chem. 292, 2773–2784 (2017).
35. Bertoli, C., Klier, S., McGowan, C., Wittenberg, C. & de Bruin, R. A. Chk1
inhibits E2F6 repressor function in response to replication stress to maintain
cell-cycle transcription. Curr. Biol. 23, 1629–1637 (2013).
36. Storre, J. et al. Silencing of the meiotic genes SMC1beta and STAG3 in somatic
cells by E2F6. J. Biol. Chem. 280, 41380–41386 (2005).
37. Courel, M., Friesenhahn, L. & Lees, J. A. E2f6 and Bmi1 cooperate in axial
skeletal development. Dev. Dyn. 237, 1232–1242 (2008).
38. Black, E. P., Hallstrom, T., Dressman, H. K., West, M. & Nevins, J. R.
Distinctions in the specificity of E2F function revealed by gene expression
signatures. Proc. Natl Acad. Sci. USA 102, 15948–15953 (2005).
39. Wang, L. et al. Programming and inheritance of parental DNA methylomes in
mammals. Cell 157, 979–991 (2014).
40. Ficz, G. et al. FGF signaling inhibition in ESCs drives rapid genome-wide
demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell
13, 351–359 (2013).
41. Tao, F. et al. beta-Catenin and associated proteins regulate lineage
differentiation in ground state mouse embryonic stem cells. Stem Cell Rep. 15,
662–676 (2020).
42. Liu, M. et al. The polycomb group protein PCGF6 mediates germline gene
silencing by recruiting histone-modifying proteins to target gene promoters. J.
Biol. Chem. 295, 9712–9724 (2020).
43. Mozzetta, C. et al. The histone H3 lysine 9 methyltransferases G9a and GLP
regulate polycomb repressive complex 2-mediated gene silencing. Mol. Cell 53,
277–289 (2014).
44. Auclair, G. et al. EHMT2 directs DNA methylation for efficient gene silencing
in mouse embryos. Genome Res. 26, 192–202 (2016).
45. Matsumura, Y. et al. H3K4/H3K9me3 bivalent chromatin domains targeted by
lineage-specific DNA methylation pauses adipocyte differentiation. Mol. Cell
60, 584–596 (2015).
46. Yuan, P. et al. Eset partners with Oct4 to restrict extraembryonic trophoblast
lineage potential in embryonic stem cells. Genes Dev. 23, 2507–2520 (2009).
47. Kumar, R. M. et al. Deconstructing transcriptional heterogeneity in
pluripotent stem cells. Nature 516, 56–61 (2014).
48. Karimi, M. M. et al. DNA methylation and SETDB1/H3K9me3 regulate
predominantly distinct sets of genes, retroelements, and chimeric transcripts
in mESCs. Cell Stem Cell 8, 676–687 (2011).
49. Wu, K. et al. SETDB1-mediated cell fate transition between 2C-like and
pluripotent states. Cell Rep. 30, 25–36 e26 (2020).
50. Tatsumi, D. et al. DNMTs and SETDB1 function as co-repressors in MAX-
mediated repression of germ cell-related genes in mouse embryonic stem cells.
PLoS ONE 13, e0205969 (2018).
51. Fonseca, G. J. et al. Diverse motif ensembles specify non-redundant DNA
binding activities of AP-1 family members in macrophages. Nat. Commun. 10,
414 (2019).
52. Cao, A. R. et al. Genome-wide analysis of transcription factor E2F1 mutant
proteins reveals that N- and C-terminal protein interaction domains do not
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23596-w ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3582 | https://doi.org/10.1038/s41467-021-23596-w |www.nature.com/naturecommunications 13
participate in targeting E2F1 to the human genome. J. Biol. Chem. 286,
11985–11996 (2011).
53. Leung, D. et al. Regulation of DNA methylation turnover at LTR
retrotransposons and imprinted loci by the histone methyltransferase Setdb1.
Proc. Natl Acad. Sci. USA 111, 6690–6695 (2014).
54. Saadeh, H. & Schulz, R. Protection of CpG islands against de novo DNA
methylation during oogenesis is associated with the recognition site of E2f1
and E2f2. Epigenet. Chromatin 7, 26 (2014).
55. Washkowitz, A. J. et al. Mga is essential for the survival of pluripotent cells
during peri-implantation development. Development 142, 31–40 (2015).
56. Shen-Li, H. et al. Essential role for Max in early embryonic growth and
development. Genes Dev. 14, 17–22 (2000).
57. Leseva, M., Santostefano, K. E., Rosenbluth, A. L., Hamazaki, T. & Terada, N.
E2f6-mediated repression of the meiotic Stag3 and Smc1beta genes during
early embryonic development requires Ezh2 and not the de novo
methyltransferase Dnmt3b. Epigenetics 8, 873–884 (2013).
58. Ecco, G., Imbeault, M. & Trono, D. KRAB zinc finger proteins. Development
144, 2719–2729 (2017).
59. Tsumura, A. et al. Maintenance of self-renewal ability of mouse embryonic
stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and
Dnmt3b. Genes Cells 11, 805–814 (2006).
60. Meilinger, D. et al. Np95 interacts with de novo DNA methyltransferases,
Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV
promoter in embryonic stem cells. EMBO Rep. 10, 1259–1264 (2009).
61. Bouyssie, D. et al. Proline: an efficient and user-friendly software suite for
large-scale proteomics. Bioinformatics 36, 3148–3155 (2020).
62. Leporcq, C. et al. TFmotifView: a webserver for the visualization of
transcription factor motifs in genomic regions. Nucleic Acids Res. 48,
W208–W217 (2020).
Acknowledgements
We are grateful to Dr. Jacqueline Lees for providing E2f6-knockout mice. This work was
supported by the European Research Council (ERC Consolidator grant number 615371 to
M.W.), the Agence Nationale de la Recherche (ANR), the Institut National du Cancer
(INCa), the Deutsche Forschungsgemeinschaft (DFG, grant number 63465200 to C.H.), and
the ITI InnoVec of the University of Strasbourg, CNRS and Inserm (IdEx ANR-10-IDEX-
0002, SFRI ANR-20-SFRI-0012). T.D. was recipient of a Doctoral fellowship from the French
Ministry for Higher Education and Research. Mass spectrometry instrumentation was
granted by the University of Strasbourg (IdEx Equipement mi-lourd 2015).
Author contributions
T.D., M.T., U.F., H.A.A., J.V., J.C., P. Hammann, S.K., U.L., G. Alvarez, G. Auclair, and
J.H. performed the experiments. A.F.B., M.D., P. Hansen, and P.N.R. performed bioin-
formatic analysis of sequencing data. J.C. performed the bioinformatic analysis of mass
spectrometry data. M.T., C.H. and M.W. designed the study and supervised the
experiments. M.T. and M.W. wrote the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41467-021-23596-w.
Correspondence and requests for materials should be addressed to M.T., C.H. or M.W.
Peer review information Nature Communications thanks the anonymous reviewers for
their contributions to the peer review of this work. Peer review reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2021
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23596-w
14 NATURE COMMUNICATIONS |         (2021) 12:3582 | https://doi.org/10.1038/s41467-021-23596-w |www.nature.com/naturecommunications
